Skip to main content
Egyptian Liver Journal

Table 2 Comparison between group 2 a and b regarding I-FABP results

From: Effect of HCV treatment with DAAs on serum intestinal fatty acid binding protein (I-FABP) as a marker of intestinal permeability in HCV/HIV co-infected patients

 

Group 2a HCV/HIV on HAART ( n  = 25)

Group 2b HCV/HIV HAART naive ( n  = 25)

P -value

Median

1st quartile

3rd quartile

Median

1st quartile

3rd quartile

I-FABP (before HCV treatment)

11.00

7.12

11.90

8.60

7.50

14.00

1.000

I-FABP (after HCV treatment)

17.86

15.00

31.00

18.20

15.10

21.40

0.776

Back to article page